To Assess the Effect of 336 Days Exposure of Paractin® on Pain & Disease Progression in Patients Suffering From Osteoarthritis of Knee Joint.

NCT04833946 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Knee Osteoarthritis (Knee OA)

Interventions

OTHER: Andrographis paniculata [150 mg]
OTHER: Microcrystalline Cellulose (MCC)

Sponsor

Vedic Lifesciences Pvt. Ltd.